Hepagam B

/ Tzamal

See prescribing information for full details.

Prevention of hepatitis B recurrence following liver transplantation: For the prevention of hepatitis B recurrence following liver transplantation, in HBsAg-positive liver transplant patients.
HepaGam B should be administered intravenously for this indication. Postexposure prophylaxis: For the treatment of acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg positive persons and household exposure to persons with acute HBV infection in the following settings:
Acute exposure to blood containing HBsAg: Following either parenteral exposure (needlestick, bite, sharps), direct mucous membrane contact (accidental splash), or oral ingestion (pipetting accident), involving HBsAg-positive materials such as blood, plasma or serum.
Perinatal exposure of infants born to HBsAg-positive mothers: Infants born to mothers positive for HBsAg with or without HBeAg.
Sexual exposure to HBsAg-positive persons: Sexual partners of HBsAg-positive persons.
Household exposure to persons with acute HBV infection: Infants less than 12 months old whose mother or primary caregiver is positive for HBsAg.
Other household contacts with an identifiable blood exposure to the index patient.
HepaGam B is indicated for intramuscular use only for these post-exposure prophylaxis indications.

See prescribing information for full details.